Clinical Trial Update: Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion [Phase 1]

View source ↗

Summary

Phase I study of HSK41959 for advanced solid tumors with MTAP deletion is currently recruiting, indicating early-stage evaluation in this genetic subset of canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• HSK41959

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING